| Date Filed | Type | Description |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2022 |
4
| MARTELL RON (President, CEO and Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 506,250 shares
@ $0 |
|
| 03/23/2022 |
4
| MARTELL RON (President, CEO and Director) has filed a Form 4 on Jasper Therapeutics, Inc.|
Txns:
| Granted 1,704,328 options to buy
@ $3.54, valued at
$6M
|
|
| 03/21/2022 |
3
| MARTELL RON (President, CEO and Director) has filed a Form 3 on Jasper Therapeutics, Inc. |
| 08/11/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/03/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 10/28/2015 |
4
| MARTELL RON (Executive Chairman) has filed a Form 4 on KALOBIOS PHARMACEUTICALS INC|
Txns:
| Granted 3,125 options to buy
@ $1.9, valued at
$5.9k
|
|
| 09/28/2015 |
4
| MARTELL RON (Executive Chairman) has filed a Form 4 on KALOBIOS PHARMACEUTICALS INC|
Txns:
| Granted 3,125 options to buy
@ $1.93, valued at
$6k
|
|
| 09/22/2015 |
4
| MARTELL RON (Executive Chairman) has filed a Form 4 on KALOBIOS PHARMACEUTICALS INC|
Txns:
| Granted 3,125 options to buy
@ $2.01, valued at
$6.3k
|
|
| 07/30/2015 |
4
| MARTELL RON (Executive Chairman) has filed a Form 4 on KALOBIOS PHARMACEUTICALS INC|
Txns:
| Granted 3,125 options to buy
@ $2.16, valued at
$6.8k
|
|
| 06/30/2015 |
4
| MARTELL RON (Executive Chairman) has filed a Form 4 on KALOBIOS PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $0.49, valued at
$12.3k
|
|
| 05/28/2015 |
4
| MARTELL RON (Executive Chairman) has filed a Form 4 on KALOBIOS PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $0.53, valued at
$13.3k
|
|
| 04/27/2015 |
4
| MARTELL RON (Director) has filed a Form 4 on KALOBIOS PHARMACEUTICALS INC|
Txns:
| Granted 30,000 restricted stock units
@ $0
Granted 30,000 options to buy
@ $0.57, valued at
$17.1k
|
|
| 11/20/2014 |
4
| MARTELL RON (CEO) has filed a Form 4 on Sevion Therapeutics, Inc.|
Txns:
| Granted 56,364 options to buy
@ $0.83, valued at
$46.8k
|
|
| 06/26/2014 |
4/A
| MARTELL RON (CEO) has filed a Form 4 on SENESCO TECHNOLOGIES INC|
Txns:
| Granted 400,000 options to buy
@ $2.66, valued at
$1.1M
|
|
| 01/03/2013 |
4
| MARTELL RON (President and CEO) has filed a Form 4 on NeurogesX Inc|
Txns:
| Exercised 25,000 restricted stock units
@ $0 |
|
| 03/15/2012 |
4
| MARTELL RON (President and CEO) has filed a Form 4 on NeurogesX Inc|
Txns:
| Granted 300,000 options to buy
@ $0.48, valued at
$144k
|
|
| 02/23/2012 |
4/A
| MARTELL RON (President and CEO) has filed a Form 4 on NeurogesX Inc|
Txns:
| Granted 500,000 options to buy
@ $1.07, valued at
$535k
Granted 100,000 restricted stock units
@ $0 |
|
| 02/01/2012 |
4
| MARTELL RON (President and CEO) has filed a Form 4 on NeurogesX Inc|
Txns:
| Granted 500,000 options to buy
@ $1.07, valued at
$535k
Granted 100,000 restricted stock units
@ $0 |
|
| 01/04/2012 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 10/07/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/12/2011 |
4
| MARTELL RON (CEO) has filed a Form 4 on PONIARD PHARMACEUTICALS, INC.|
Txns:
| Exercised 162,500 restricted stock units
@ $0 |
|
| 02/16/2011 |
4
| MARTELL RON (CEO) has filed a Form 4 on PONIARD PHARMACEUTICALS, INC.|
Txns:
| Granted 576,924 restricted stock units
@ $0 |
|
| 02/08/2011 |
4
| MARTELL RON (CEO) has filed a Form 4 on PONIARD PHARMACEUTICALS, INC.|
Txns:
| Exercised 31,250 restricted stock units
@ $0 |
|
| 01/12/2011 |
4
| MARTELL RON (CEO) has filed a Form 4 on PONIARD PHARMACEUTICALS, INC.|
Txns:
| Exercised 25,000 restricted stock units
@ $0 |
|
| 01/04/2011 |
4
| MARTELL RON (CEO) has filed a Form 4 on PONIARD PHARMACEUTICALS, INC.|
Txns:
| Exercised 292,208 restricted stock units
@ $0 |
|
| 06/11/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/13/2010 |
4
| MARTELL RON (CEO) has filed a Form 4 on PONIARD PHARMACEUTICALS, INC.|
Txns:
| Granted 325,000 restricted stock units
@ $0 |
|
| 03/29/2010 |
4
| MARTELL RON (CEO) has filed a Form 4 on PONIARD PHARMACEUTICALS, INC.|
Txns:
| Bought 1,200 shares
@ $1.26, valued at
$1.5k
Bought 10,915 shares
@ $1.24, valued at
$13.5k
|
|
| 02/08/2010 |
4
| MARTELL RON (CEO) has filed a Form 4 on PONIARD PHARMACEUTICALS, INC.|
Txns:
| Granted 292,208 restricted stock units
@ $0 |
|
|